Importantly, the authors found that the CSF YKL-40/Aβ42 ratio was similar to t-tau/Aβ42 and p-tau-181/Aβ42 ratios in predicting the risk of developing cognitive impairment [184]. The gene discussed is MAPT; the disease is Cognitive impairment.